Pfizer - Collegeville, PA
posted 3 months ago
The Clinical Lead (CL) for Internal Medicine RU (IMRU) at Pfizer will serve as a pivotal thought leader in the clinical research domain, particularly focusing on the burgeoning field of cardiometabolic diseases. This role encompasses the responsibility of formulating a comprehensive strategy for early clinical development programs, emphasizing innovative design, medical and scientific excellence, and adherence to the highest ethical standards. The CL will spearhead the clinical development strategy and oversee the execution of research projects that target cardiometabolic diseases and related conditions, including cardiovascular disease, heart failure, renal impairment, obesity, and diabetes. This position requires the translation of pre-clinical observations into clinical experiments and studies aimed at establishing proof of pharmacology, proof of mechanism, and proof of concept for new candidate medicines. In this role, the CL will leverage extensive medical and clinical knowledge to convert clinical research ideas into high-quality decision-making data. Collaboration with subject matter experts from statistics, clinical pharmacology, and other team members will be essential. The CL will act as the primary clinical development contact for the Research Project Leader for each assigned project, integrating scientific knowledge with operational expertise to ensure creativity, excellence, and integrity in clinical development. Additionally, the CL will be the principal contact for medical and safety issues throughout the study execution process, working closely with study managers, external collaborators, and clinical trial sites. The CL will also be responsible for establishing and nurturing relationships with key clinical experts, academic institutions, and clinical trial sites, utilizing these connections to foster collaborations and enhance Pfizer's medical and scientific reputation. This role requires a collaborative approach across the enterprise, coordinating contributions from Discovery & Early Development lines and broader Pfizer Research & Development colleagues to advance drug development programs. The CL will ensure alignment and support from leadership stakeholders to streamline end-to-end clinical development plans, positioning them uniquely at the intersection of bench and bedside, and playing a crucial role in the ideation and maturation of cutting-edge clinical science applied to drug development.